Laboratory animals as surrogate models of human obesity
- PMID: 22301857
- PMCID: PMC4010334
- DOI: 10.1038/aps.2011.203
Laboratory animals as surrogate models of human obesity
Abstract
Obesity and obesity-related metabolic diseases represent a growing socioeconomic problem throughout the world. Great emphasis has been put on establishing treatments for this condition, including pharmacological intervention. However, there are many obstacles and pitfalls in the development process from pre-clinical research to the pharmacy counter, and there is no certainty that what has been observed pre-clinically will translate into an improvement in human health. Hence, it is important to test potential new drugs in a valid translational model early in their development. In the current mini-review, a number of monogenetic and polygenic models of obesity will be discussed in view of their translational character.
References
-
- Padwal RS, Jajumdar SR. Drug treatments for obesity; orlistat sibutramine and rimonabant. Lancet. 2007;369:71–7. - PubMed
-
- Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374:1606–16. - PubMed
-
- Finer N. Executive steering committee of the sibutramine cardiovascular outcome trial. Withdrawal of sibutramine. Editorial is judgement in advance of the facts. BMJ. 2010;340:C1346. - PubMed
-
- Kondo K, Nozawa K, Tomira T, Ezaki K. Inbred strains resulting from Japanese mice. Bull Exp Anim. 1957;6:107–12.
-
- Igel M, Taylor BA, Phillips SJ, Becker W, Herberg L, Joost HG. Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain. J Mol Endocrinol. 1998;21:337–45. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
